Atypical haemolytic-uraemic syndrome: reflecting over the old and new
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000300002 |
Resumo: | Atypical haemolytic uraemic syndrome is a rare disease characterised by microangiopathic haemolytic anaemia, thrombocytopaenia and predominant renal impairment in the absence of Shiga toxin-producing bacteria. For long time it has been difficult to distinguish it from other thrombotic microangiopathies, but in the last decade advances have been made in understanding the pathogenesis of atypical haemolytic uraemic syndrome as a disorder of alternative pathway of the complement system. Knowledge of mutations and polymorphisms in the genes encoding the complement regulatory proteins revealed clinical importance in the management of the patients, altering not only the transplantation perspective but also leading to the search for new drugs, something that will potentially change the poor prognosis of these patients. This article reviews the differential diagnosis of this thrombotic microangiopathy to reflect on current treatment options and discuss new therapies |
id |
RCAP_92a45c18c2e28d2f9d609d7b13a7ff51 |
---|---|
oai_identifier_str |
oai:scielo:S0872-01692012000300002 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Atypical haemolytic-uraemic syndrome: reflecting over the old and newAlternative complement pathwayatypical haemolyticuraemic syndromeeculizumabplasmapheresistransplantationAtypical haemolytic uraemic syndrome is a rare disease characterised by microangiopathic haemolytic anaemia, thrombocytopaenia and predominant renal impairment in the absence of Shiga toxin-producing bacteria. For long time it has been difficult to distinguish it from other thrombotic microangiopathies, but in the last decade advances have been made in understanding the pathogenesis of atypical haemolytic uraemic syndrome as a disorder of alternative pathway of the complement system. Knowledge of mutations and polymorphisms in the genes encoding the complement regulatory proteins revealed clinical importance in the management of the patients, altering not only the transplantation perspective but also leading to the search for new drugs, something that will potentially change the poor prognosis of these patients. This article reviews the differential diagnosis of this thrombotic microangiopathy to reflect on current treatment options and discuss new therapiesSociedade Portuguesa de Nefrologia2012-07-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000300002Portuguese Journal of Nephrology & Hypertension v.26 n.3 2012reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000300002Farinha,Anainfo:eu-repo/semantics/openAccess2024-02-06T17:04:39Zoai:scielo:S0872-01692012000300002Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:18:49.153663Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
title |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
spellingShingle |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new Farinha,Ana Alternative complement pathway atypical haemolyticuraemic syndrome eculizumab plasmapheresis transplantation |
title_short |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
title_full |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
title_fullStr |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
title_full_unstemmed |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
title_sort |
Atypical haemolytic-uraemic syndrome: reflecting over the old and new |
author |
Farinha,Ana |
author_facet |
Farinha,Ana |
author_role |
author |
dc.contributor.author.fl_str_mv |
Farinha,Ana |
dc.subject.por.fl_str_mv |
Alternative complement pathway atypical haemolyticuraemic syndrome eculizumab plasmapheresis transplantation |
topic |
Alternative complement pathway atypical haemolyticuraemic syndrome eculizumab plasmapheresis transplantation |
description |
Atypical haemolytic uraemic syndrome is a rare disease characterised by microangiopathic haemolytic anaemia, thrombocytopaenia and predominant renal impairment in the absence of Shiga toxin-producing bacteria. For long time it has been difficult to distinguish it from other thrombotic microangiopathies, but in the last decade advances have been made in understanding the pathogenesis of atypical haemolytic uraemic syndrome as a disorder of alternative pathway of the complement system. Knowledge of mutations and polymorphisms in the genes encoding the complement regulatory proteins revealed clinical importance in the management of the patients, altering not only the transplantation perspective but also leading to the search for new drugs, something that will potentially change the poor prognosis of these patients. This article reviews the differential diagnosis of this thrombotic microangiopathy to reflect on current treatment options and discuss new therapies |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-07-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000300002 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000300002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000300002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
dc.source.none.fl_str_mv |
Portuguese Journal of Nephrology & Hypertension v.26 n.3 2012 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817551041594392576 |